CAS: 26652-09-5; 4-(2-(((1S,2R)-1-Hydroxy-1-(4-Hydroxyphenyl)Propan-2-yl)Amino)Ethyl)Phenol

该化合物是一种合成药物,主要用作抑制早产的药剂,通过放松子宫滑动肌肉来抑制早产.它属于乙型过敏性激动剂类,具体针对乙型-2肾上腺受体.里托丁酸的特征是能够诱发支气和血管通缩,这可能导致副作用,如心率和呼吸率增加.里托丁酸的化学结构包括苯丙基羟基化合物组和第三剂,有助于其药用活动.它通常通过静脉注射或口服进行,这取决于临床情况.里托丁酸在推迟分娩时的效力使其在产科护理中成为一个重要的选择,尽管由于对副作用和替代疗法的提供情况的关切而减少.该物质的使用被划为化学文摘社登记号26652-09-5,该物质在化学数据库中的独特识别.与任何药物一样,其好处都必须与潜在风险相权衡,并且对于密切监测治疗期间的病人至关重要.

结构式图片

MSDS等安全信息

    上下游产品

    Nitroethane p-benzyloxybenzaldehyde 2-[4-(benzyloxy)phenyl]acetaldehyde (1R,2S)-1-(4-benzyloxyphenyl)-2-[2-(4-benzyloxyphenyl)ethyl]amino-1-propanol

    合成工艺路线路线简述

      📜4-{(1S,2R)-2-[2-(4-Benzyloxy-Phenyl)-Ethylamino]-1-Hydroxy-Propyl}-Phenol; hydroChloride 在 Palladium On Activated Charcoal 氢气体系中,用 乙醇作为反应溶剂,获得 (+/-)-Ritodrine
      参考文献:β-苯基乙胺衍生物x N-(羟基和甲氧基芳烷基)衍生物的合成† •
      标题:β-苯基乙胺衍生物x N-(羟基和甲氧基芳烷基)衍生物的合成† •
      摘要:描述了具有以下一般结构的化合物的合成和某些药理特性:
      Doi:10.1002/Recl.19730921113

      海关参考信息

      专利信息


      专利号:WO-0112817-A1
      优先权日:1999-08-12
      标题:Evolution and use of enzymes for combinathorial and medicinal chemistry
      发明人:KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
      权利人:MAXYGEN INC; LIU LU; KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
      摘要:This invention provides libraries of recombinant derivatizing enzymes that are useful for biocatalytic synthesis of derivatives oforganic molecules, including lead compounds for pharmaceutical use. The recombinant derivatizing enzymes catalyze reactions such as modification or replacement of functional groups on the organicmolecules, or addition of chemical moieties onto preexisting functional groups. The use of recombinant enzyme libraries enables one to obtain enzymes that catalyze the formation of organic molecule derivatives that could not otherwise be made using only naturally occurring enzymes.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1371/journal.pone.0218897
      摘要:Miller TW, Amason JD, Garcin ED, Lamy L, Dranchak PK, Macarthur R, Braisted J, Rubin JS, Burgess TL, Farrell CL, Roberts DD, Inglese J. Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors. PLoS ONE. 2019 Jul 05;14(7):e0218897. doi: 10.1371/journal.pone.0218897.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知